These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 14751287)

  • 1. Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain.
    Mullaney BC; Johnston MV; Blue ME
    Neuroscience; 2004; 123(4):939-49. PubMed ID: 14751287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of MeCP2 in the Rett syndrome and the non-Rett syndrome brain.
    Armstrong DD; Deguchi K; Antallfy B
    J Child Neurol; 2003 Oct; 18(10):683-7. PubMed ID: 14649549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the methyl-CpG-binding protein MeCP2 in rat brain. An ontogenetic study.
    Cassel S; Revel MO; Kelche C; Zwiller J
    Neurobiol Dis; 2004 Mar; 15(2):206-11. PubMed ID: 15006690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation.
    Shahbazian MD; Antalffy B; Armstrong DL; Zoghbi HY
    Hum Mol Genet; 2002 Jan; 11(2):115-24. PubMed ID: 11809720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.
    Braunschweig D; Simcox T; Samaco RC; LaSalle JM
    Hum Mol Genet; 2004 Jun; 13(12):1275-86. PubMed ID: 15115765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A transcriptional repressor MeCP2 causing Rett syndrome is expressed in embryonic non-neuronal cells and controls their growth.
    Nagai K; Miyake K; Kubota T
    Brain Res Dev Brain Res; 2005 Jun; 157(1):103-6. PubMed ID: 15939091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice.
    Fukuda T; Itoh M; Ichikawa T; Washiyama K; Goto Y
    J Neuropathol Exp Neurol; 2005 Jun; 64(6):537-44. PubMed ID: 15977646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells.
    Jung BP; Jugloff DG; Zhang G; Logan R; Brown S; Eubanks JH
    J Neurobiol; 2003 Apr; 55(1):86-96. PubMed ID: 12605461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MeCP2 regulates GFAP expression within the developing brain.
    Forbes-Lorman RM; Kurian JR; Auger AP
    Brain Res; 2014 Jan; 1543():151-8. PubMed ID: 24269336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MeCP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis.
    Cohen DR; Matarazzo V; Palmer AM; Tu Y; Jeon OH; Pevsner J; Ronnett GV
    Mol Cell Neurosci; 2003 Apr; 22(4):417-29. PubMed ID: 12727440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry.
    LaSalle JM; Goldstine J; Balmer D; Greco CM
    Hum Mol Genet; 2001 Aug; 10(17):1729-40. PubMed ID: 11532982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders.
    Samaco RC; Nagarajan RP; Braunschweig D; LaSalle JM
    Hum Mol Genet; 2004 Mar; 13(6):629-39. PubMed ID: 14734626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analyses of MeCP2 mutations associated with Rett syndrome using transient expression systems.
    Kudo S; Nomura Y; Segawa M; Fujita N; Nakao M; Dragich J; Schanen C; Tamura M
    Brain Dev; 2001 Dec; 23 Suppl 1():S165-73. PubMed ID: 11738866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.
    Samaco RC; Hogart A; LaSalle JM
    Hum Mol Genet; 2005 Feb; 14(4):483-92. PubMed ID: 15615769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice.
    Luikenhuis S; Giacometti E; Beard CF; Jaenisch R
    Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6033-8. PubMed ID: 15069197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
    Chen RZ; Akbarian S; Tudor M; Jaenisch R
    Nat Genet; 2001 Mar; 27(3):327-31. PubMed ID: 11242118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of MeCP2 function is associated with distinct gene expression changes in the striatum.
    Zhao YT; Goffin D; Johnson BS; Zhou Z
    Neurobiol Dis; 2013 Nov; 59():257-66. PubMed ID: 23948639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Phospho-MeCP2s in the Developing Rat Brain and Function of Postnatal MeCP2 in Cerebellar Neural Cell Development.
    Liu F; Ni JJ; Sun FY
    Neurosci Bull; 2017 Feb; 33(1):1-16. PubMed ID: 27995568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MeCP2 in neurons: closing in on the causes of Rett syndrome.
    Caballero IM; Hendrich B
    Hum Mol Genet; 2005 Apr; 14 Spec No 1():R19-26. PubMed ID: 15809268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation.
    Balmer D; Goldstine J; Rao YM; LaSalle JM
    J Mol Med (Berl); 2003 Jan; 81(1):61-8. PubMed ID: 12545250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.